Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: A systematic review and meta-analysis

BJU International

Volumn 111, Issue 2, 2013, Pages 312-323

  Teng, Jingfei ^a,b   Zhang, Dongxu ^a   Li, Yao ^a   Yin, Lei ^a   Wang, Kai ^a   Cui, Xingang ^a   Xu, Danfeng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

benign prostate hyperplasia; photoselective vaporization of the prostate; transurethral resection of the prostate

Indexed keywords

ARTICLE; BLADDER CATHETERIZATION; BLADDER PERFORATION; BLOOD TRANSFUSION; FOLLOW UP; GREEN LIGHT; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL PROSTATE SYMPTOM SCORE; LENGTH OF STAY; LIGHT; LOWER URINARY TRACT SYMPTOM; MALE; META ANALYSIS; MINIMALLY INVASIVE SURGERY; OPERATION DURATION; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REOPERATION; SYSTEMATIC REVIEW; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL RESECTION; TRANSURETHRAL RESECTION SYNDROME; URETHRA STRICTURE; URINE FLOW RATE;

BLOOD LOSS, SURGICAL; HUMANS; LASER COAGULATION; LENGTH OF STAY; MALE; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REOPERATION; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 84873114066     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11395.x     Document Type: Article

References (36)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL,. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-479
2. Reich O, Gratzke C, Stief CG,. Techniques and long-term results of surgical procedures for BPH. Eur Urol 2006; 49: 970-978; discussion 978
3. de la Rosette JJ, Alivizatos G, Madersbacher S, et al. EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2001; 40: 256-263; discussion 264
4. Rassweiler J, Teber D, Kuntz R, Hofmann R,. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 2006; 50: 969-979; discussion 980
5. Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008; 180: 246-249
6. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG,. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995; 332: 75-79
7. Malek RS, Kuntzman RS, Barrett DM,. High power potassium-titanyl- phosphate laser vaporization prostatectomy. J Urol 2000; 163: 1730-1733
8. Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 2010; 58: 349-355
9. Tzortzis V, Gravas S, de la, Rosette J,. Minimally invasive surgical treatments for benign prostatic hyperplasia. Eur Urol Suppl 2009; 8: 513-522
10. Malek RS, Kuntzman RS, Barrett DM,. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005; 174 (4 Pt 1): 1344-1348
11. Ruszat R, Seitz M, Wyler SF, et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008; 54: 893-901
12. Wong C, Araki M, Tonkin JB,. High-power potassium-titanyl-phosphate or lithium triboride laser photoselective vaporization prostatectomy for benign prostatic hyperplasia: a systematic approach. J Endourol 2007; 21: 1141-1144
13. Spaliviero M, Araki M, Wong C,. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 2008; 22: 2341-2347
14. Chen J, Wang M, Wang S, et al. 160-Watt lithium triboride laser vaporization versus transurethral resection of prostate: a prospective nonrandomized two-center trial. Urology 2012; 79: 650-654
15. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12
16. Kjaergard LL, Villumsen J, Gluud C,. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135: 982-989
17. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613
18. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm. Accessed 19 October 2009
19. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748
20. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
21. Bachmann A, Schurch L, Ruszat R, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005; 48: 965-972
22. Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C,. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 2008; 71: 247-251
23. Tasci AI, Tugcu V, Sahin S, Zorluoglu F,. Rapid communication: photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008; 22: 347-353
24. Tugcu V, Tasci AI, Sahin S, Zorluoglu F,. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008; 22: 1519-1525
25. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ,. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 2010; 105: 964-969
26. Capitan C, Blazquez C, Martin MD, Hernandez V, de la, Pena E, Llorente C,. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 2011; 60: 734-739
27. Lukacs B, Loeffler J, Bruyere F, et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial, 2012/02/22 edn. Eur Urol 2012; 61: 1165-1173
28. Tan A, Liao C, Mo Z, Cao Y,. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 2007; 94: 1201-1208
29. Ruszat R, Wyler SF, Seitz M, et al. Comparison of potassium-titanyl- phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int 2008; 102: 1432-1438; discussion 1438-9
30. Pereira-Correia JA, Sousa KD, Santos JB, et al. GreenLight HPS 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation, 2012/01/20 edn. BJU Int 2012; [Epub ahead of print] doi: 10.1111/j.1464-10X.2011.10878.x
31. Woo H, Reich O, Bachmann A, et al. Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (≥80 mL). Eur Urol Suppl 2008; 7: 161-192
32. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH,. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 2007; 100: 593-598; discussion 598
33. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T,. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005; 173: 158-160
34. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE,. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005; 19: 1196-1198
35. Lee R, Gonzalez RR, Te AE,. The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol 2006; 24: 405-409
36. Malek RS, Kang HW, Coad JE, Koullick E,. Greenlight photoselective 120-watt 532-nm lithium triborate laser vaporization prostatectomy in living canines. J Endourol 2009; 23: 837-845